Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Smallpox

Smallpox is an acute infectious disease unique to humans, caused by either of two virus variants named Variola major and Variola minor. Also known by the Latin names Variola or Variola vera; a derivative of the Latin varius, meaning spotted, or varus, meaning "pimple". The term "smallpox" was first used in Europe in the 15th century to distinguish variola from the great pox . Smallpox localizes in small blood vessels of the skin and in the mouth and throat. In the skin, this results in the characteristic maculopapular rash, which evolves into raised vesicles, then into fluid-filled pustules. V. major produces a more serious disease and has an overall mortality rate of 30–35%. V. minor causes a milder form of disease which kills ~1% of its victims. Blindness resulting from corneal ulceration and scarring, and limb deformities due to arthritis and osteomyelitis are less common complications, seen in about 2-5% of cases.Smallpox is believed to have emerged in human populations about 10,000 BC. During the 20th century, it is estimated that smallpox was responsible for 300–500 million deaths. As recently as 1967, the World Health Organization estimated that 15 million people contracted the disease and that two million died in that year. After successful vaccination campaigns throughout the 19th and 20th centuries, the WHO certified the eradication of smallpox in 1979. (From the Wikpedia article Smallpox.)

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Smallpox:

Pubmed Logo
A mouse-based assay for the pre-clinical neurovirulence assessment of vaccinia virus-based smallpox vaccines.
Post-vaccinal encephalitis, although relatively uncommon, is a known...
10th November, 2009
FDA, Division of Viral Products, Building 29A, Room 2C-20, Lincoln Drive, Biologicals. 2009 Nov 5.
DOI Direct Link
Production of pharmaceutical-grade plasmids at high concentration and high supercoiled percentage.
The increased use of plasmid-based vaccines to replace their more...
10th November, 2009
VGX Pharmaceuticals, Inc., The Woodlands, TX 77381, United States. Vaccine. 2009 Nov 4.
DOI Direct Link
Capturing of cell culture-derived modified Vaccinia Ankara virus by ion exchange and pseudo-affinity membrane adsorbers.
Smallpox is an acute, highly infectious viral disease unique to humans,...
6th November, 2009
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Biotechnol Bioeng. 2009 Nov 4.
DOI Direct Link
In vitro Prevention of Vaccinia and Herpesvirus Infection Spread in Explanted Human Corneas by N-Chlorotaurine.
Objective: Weak oxidants produced by activated human leukocytes are proven...
6th November, 2009
Department of Hygiene, Microbiology and Social Medicine, Innsbruck Medical Ophthalmic Res. 2009 Nov 2;43(3):145-152.
DOI Direct Link
Recombinant A27 protein synergizes with modified vaccinia Ankara in conferring protection against a lethal vaccinia virus challenge.
Highly attenuated modified vaccinia virus Ankara (MVA) is being considered...
6th November, 2009
Division of Viral Products, Center for Biologics Evaluation and Research, Vaccine. 2009 Oct 31.
DOI Direct Link

View more research publications.

Press Releases About Smallpox:

BioPortfolio Logo
The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 1st December, 2008
KVISTGARD, Denmark, December 1 /PRNewswire/ -- Following a Request for Proposal issued in 2007 with the intent to procure an MVA-based, third generation smallpox vaccine, Public Works and Government
Affymetrix Announces Completion of Smallpox Array Set Developed with CDC 1st January, 1970 Affymetrics
Affymetrix Announces Completion of Smallpox Array Set Developed with CDC - Seven-Array Set Will Enable Rapid Resequencing of the Entire Smallpox Genome - SANTA CLARA, Calif., Feb. 19 --
The Licensing Review contains news, analysis and opinions on the 1st January, 1970 Datamonitor
Datamonitor October edition of The Licensing Review contains news, analysis and opinions on the healthcare licensing industry. Scope
The Infectious Diseases Review brings you the latest news, expert 1st January, 1970 Datamonitor
Datamonitor's October edition of the Infectious Diseases Review brings you the latest news, expert analysis and research in the infectious

BioNews Results for Smallpox:

RSS Logo
BioPortfolio Logo
Fearing a flu vaccine, and wanting more of it
Helena Independent:  Nov 12 2009 10:31PM Matching: smallpox
Chimerix to Present at Two Upcoming Investor Conferences
Freshnews.com:  Nov 12 2009 2:20PM Matching: smallpox
Chimerix to Present at Two Upcoming Investor Conferences
Pharma Live:  Nov 12 2009 2:15PM Matching: smallpox
BUY OR SELL-U.S. order key for vaccine maker Bavarian Nordic
Forbes.com:  Nov 12 2009 2:42PM Matching: smallpox
BUY OR SELL-U.S. order key for vaccine maker Bavarian Nordic
FinanzNachrichten.de:  Nov 12 2009 2:38PM Matching: smallpox
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Smallpox Clinical Trials:

Clinical Trials Logo
Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults

Smallpox Patents:

USPTO Logo
US Patent No.Title
7569188 Surface plasmon amplification by stimulated emission of radiation (SPASER)
7576319 Systems for differential ion mobility analysis
7576854 Arrays of nano structures for surface-enhanced raman scattering
7578969 Decontamination system for mail and other articles
7579004 Naturally processed measles virus peptides eluted from class II HLA molecules

View more patents.

Companies working in the area of Smallpox from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

Acambis plc

Acambis is a biopharmaceutical company discovering, developing and manufacturing vaccines to prevent and treat infectious diseases. Employing some 160 people, it is based in Cambridge, UK, and...
www.acambis.com/        View full profile
Thumbshot

Cangene Corporation

Cangene is a world leader in the development , manufacture, and commercialization of specialty hyperimmune plasma and biotechnology products. Cangene has built two decades of success with the life...
www.cangene.com/        View full profile
Thumbshot

Chimerix, Inc

Chimerix Inc. is a privately held biotechnology company creating and developing orally available medicines from bioactive molecules. Application of Chimerix's proprietary technology enhances oral...
www.chimerix-inc.com/        View full profile
Thumbshot

View more Smallpox related companies.

BioPortfolio Ltd. offers e-mail and postal lists for Smallpox scientists - we have details of around 767 individuals working on Smallpox .


This page has been viewed 503 times
Recent Search Terms used to find this page: chimerix smallpox press release | prevalence of smallpox of united states in 2009 | the prevalence of smallpox in united states 2009 | importance of smallpox 2oo9 | smallpox 2009 | smallpox 2009 | smallpox 2009 | chimerix smallpox rfp | smallpox 2009 | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Smallpox across BioPortfolio, or for Smallpox Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.